Pharma woes: Dinesh Thakur and Prashant Reddy on India’s regulatory shortcomings
The authors of The Truth Pill discuss India’s non-compliance with scientific methodology.
-NaN:NaN:NaN
For a better listening experience, download the Newslaundry app
Support Independent Media
The media must be free and fair, uninfluenced by corporate or state interests. That's why you, the public, need to pay to keep news free.
ContributeIn their 2022 book The Truth Pill, lawyer Prashant Reddy T and public health activist Dinesh S Thakur explored various aspects of modern pharmacology and pharmaceutical practices in India.
Now, in this conversation with Newslaundry’s Abhinandan Sekhri on February 9, they talked about the shortcomings of pharmaceutical regulations in India. Prashant quoted a former drug controller, who said, “If I had to apply American standards of quality to the Indian industry, I’ll have to shut down more than half the plants.”
This lack of regulatory accountability and non-compliance with scientific methodology can have serious consequences for consumers. Dinesh and Prashant explained other pressing concerns facing healthcare in India – rising drug failures, a surge in fixed-dose combinations, and the lack of regulatory structures for ayurvedic medicines.
Watch.
Venue partner: The Quorum, Gurgaon
NL Interview: Katherine Eban on Big Pharma’s corrupt practices
Hafta 419: Big pharma in India, Parliament ruckus
Power NL-TNM Election Fund
General elections are around the corner, and Newslaundry and The News Minute have ambitious plans together to focus on the issues that really matter to the voter. From political funding to battleground states, media coverage to 10 years of Modi, choose a project you would like to support and power our journalism.
Ground reportage is central to public interest journalism. Only readers like you can make it possible. Will you?